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Since its introduction i 1977 (l), coronary angioplasty has 
increased to become th on form of myocardial 
revascularization (2). application of angio- 
plasty, as well as newe hanical revasculariza- 
tion, requires athorough knowledge ofoutcome in different 
populations. Increased interest in women’s health and the 
differing presentation f coronary disease in women (3) have 
prompted increasing interest in outcome studies of coronary 
disease in women. Women are known to develop coronary 
disease later in life than men (3). The in-hospital mortality 
after angioplasty increases with age and is higher in women 
From the Division of Cardiology, Department or Medicine, Emory 
University School of Medicine, Atlanta, Georgia. This study was presented in 
part a  the 65th Scientific Sessions of the American Heart Association, New 
Orleans, Louisiana, November 1992. 
Manuscript received April 19.1993; revised manuscript received January 
31, 1994, accepted February 28, 1994. 
Address_for: Dr. William S. Weintraub, Division of 
Cardiology, Emory University Hospital. 1364 Clifton Road Northeast. 
Atlanta, Georgia 30322. 
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as well (4-7). The relation between age and gender in 
determining outcome and whether long-term outcome differs 
aim uncertain. Thus, it is the purpose of this 
study to examine thoroughly differences in the characteris- 
tics and outcomes of women and men undergoing elective 
coronary a~gio~lasty. 
s 
From June 1990 through 
1991, 10,785 patients without previous a~~~o~~asty or coro- 
nary surgery had elective angioplady Reformed at E 
Universit spitals. Included were patients 
angioplas r stable or unstable angina pectoris or after 
several days of stabilization after acute myocardial infarc- 
tion. Those who had the procedure p 
setting of infarction were excluded. 
are referred to Emory specifically for angioplasty. Stress 
testing isnot routinely available. 
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IS. Single-vessel disease is defined as at least 
50% lumen diameter narrowing in either the left anterior 
descending, left circumflex, or right coronary artery or a 
major branch or branches. Multiple-vessel disease refers to 
the presence of rSO% lumen diameter narrowing in more 
than one of these major epicardial vessel systems. An@- 
graphic& successful arrgioplasty is said to have occurred 
when ail lesions attempted improved >20% in diameter of 
stenosis and dilated to <5O% diameter stenosis. 
Clinically success/u1 angioplasty refers t0 phic suc- 
cess without the complications of myocardial infarction, 
coronary surgery or death during the same hospital admis- 
sion. Variables defined by patient histury included hy 
sion, diabetes, severity of angina 
farction and myocardial infarction 
was defined by Canadian Cardiravascu 
tion (8). Congestive failure was defiflcd by the New York 
IIeart Association criteria. 
All angioplasty procedures 
were performed usin tandard’techniques that have previ- 
. Baseline and restudy demographic, 
clinical, at&graphic atzd procedural data including compli- 
cations were recorded ptospeciively on standardized forms 
and entered into a computerized data base. The prcangio- 
plasty, postangioplasty and restudy angiograms were mea- 
sured with validated digital electronic calipers (Sandhill 
Scientific Inc. after 1983; with a prototype 1981 to 1983) (10) 
or by hand tracing (I980 to 1981) by experienced angiogra- 
phers involved in the procedure but other than the primary 
operator. The angiographic measurements were calibrated to 
the size of the catheter. The degree of narrowing of each 
coronary artery lesior was expressed LS the percent diame- 
ter narrowing of the abnormal ent compared with the 
normal adjacent arterial segme The diameter stenosis 
recorded was the mean value determined in two views. 
These measurements were performed as an ongoing clinical 
activity, and those who made the measurements were aware 
of clinical data. 
w-up. Follow-up information was obtained 
from the patients or their referring physicians. Follow-up 
sta?us for each end point is also assessed at each subsequent 
hospitnl admission. Patients not readmitted are contacted by 
telephone or letter. Follow-up was available en 9,910 of the 
10,785 patients. Mean (*SD) length of follow-up was 3.5 + 
2.8 years. Information obtained included occurrence of 
myocardial infarction since the initial angioplasty, subse- 
quent need for an additional revascularization procedure 
@@oplasty or coronary surgery), death (cardiac plus non- 
cardiac) and recurrent angina. All follow-up information was 
recorded on standardized forms and entered into the c0m- 
puterized data base. All repeat procedures performed at 
Emory University Hospitals were confirmed from the data 
base. MyocardiaI infarctions during follow-up were ascer- 
tained largely from the patients, and thus there may be both 
underreporting and overreporting. 
dent t tests. The cIi~~ca1, n 
Overall survival (cardiac plus n 
survival were deter 
variables that were 
examined. Ejection fcti 
height bad a comside~ble number 0 
resulted in the in-hospital model 
deaths. Imputed values for mis 
model to increase the number of pati 
tation was 
bei~bt as a 
hywrtension and gender. Imp1 tation of ejection fraction 
~50% was performed using a logistic regression model with 
age, congestive heart failure, hypertension, gender, pres- 
ence of multivessel disease, history of previous my~ca~dial 
infarction and angina class as covariates. The Cox 
analyses were also repeated for hospital survivors. P 
tionality of hazards in the Cox model was checked graphi- 
cally for each variable by plotting the natural logarithm of 
cumulative hazard versus time. No major departures from 
the proportional hazards assumption were detected. Martin- 
gale residuals were plotted for the Cox model, and no 
observatitius seemed particularly outlying. The Hosmer- 
Lemeshow goodness-of-lit test did not detect 
from lit for logistic regression analysis. The 
S-Plus statistical packages were used. 
The 2,845 women were significantly older than the 7,940 
men, with a larger proportion of the women >70 and 80 
years old (Table I). More women than men had hypertension 
(54.5% vs. 40. I%), diabetes ( 3% vs. 11.7%), grade III to 
IV angina (71.5% vs. 58.4%) a congestive failure (4.3% vs. 
2.1%) (all p < O.ooOl). More men had had a previous 
myocardial infarction, and the men were taller, weighed 
more and had a larger body surface area (all p < O.OOOl). The 
ejection fractions were lower in men, and more men had 
Itnhia! Clinical c~ara~Ier~§~i~5 
_- 
Tooaal 
(I-l = 10.785) 
No. (%) 
Age (Y rl 
Mean 589 II 
40 5,868 (54.4) 
M-69 3.549 (32.9) 
>70 I.361 (12.6) 
Systemic hyperteusioa 10,785 (43.9) 
Diabetes melkot 1,479 (13.7) 
Previous myocardial 3.694 (34.3) 
i~fa~~~io~ 
Grade III-IV angina 6,348 (68.9) 
(M = 10,257: 
Congestive failure 279 (2.7) 
(11 = 10,449) 
68 -c 15 
17’1 T 33 
Body surface area (mP) 194 Z!Z 0.22 
= 9,202) 
womea Mea 
(ra = 2,845) (n = 5 940) 
No. (%I Ph. r?q p Value 
m-P 
62_c 81 57 c 13 
I, 138 (4C.0) 4,730 (59.6) 
1,069 (31.6) 2,480 (31.3) 
636 (22.4) 725 (9.1) 
2,845 (54.5) 7,940 (40.1) 
549 (!9.3) 336 il1.7) 
882 (31.0) 2,812 (35.4) 
i.956 (71.5) 4,392 (58.4) 
(a = 2,736) (n = 7,521) 
114 (4.3) 061 (2 I) 
(El = 7,x99) 
70 c 4 
186 r 3c 
1.74 + Q.IY < o.OOor 
(n = 2 397) (n = 4*805) 
variables show that 
gested more severe coronary disease (as measured by ves- 
at follow-up are shown in 
s. There was a trend toward more 
dial infarctions inwomen (1.1% vs. &X75%, 
in-hospital mortality was bigher ia; women (0.7% vs. 0. I%, 
yocardial infection, two 
u, 0 other cardiac and two 
nonmdiac. correlates of in-hospital death are shown in 
Angiographic Characteristics 
TOUl Women 
(n = 10,?55) (n = 2,845) 
No. (o/o) No. (%I 
Mean ejection hctioa 582 II 59 + 12 
Ejection fraction <50% 1,236 (16.7) 298 (14.4) 
(n = 7,389: (n = L.067) 
Multivessel disease 3,119 129.5) 716 (25.2) 
Multisite angioplasty 2,544 (23.6) 613 (2l.R 
Artery size (mm) 2.9 t 0.6 2.8 k 0.6 
(IF = 6,3M) (n = 1,813) 
Artery size/body &ace area I.50 f 0.40 1.62 + 0.45 
(n = 4,881) (n = 1,402) 
Stenosis before angioplhy i%) 75.2 + 13.8 74.7 + 13.4 
Da!a presented are mean values .+: SD or number (o/o) of patients. 
Men 
(n = 7.940) 
No. (%i 
58t II 
938 (17.6) 
(n = 5,322) 
2,463 (31.0) 
1,931 (24.3) 
2.9 2 0.6 
(n = 4,491) 
1.46 + 0.36 
(n = 3,479) 
15.4 2 13.9 
p Value 
< 0.0001 
O&x9 
< 0.0001 
0.018 
- 
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TOld Women Men 
(n = 10,785) (n = 2.845) (n = 7,940) 
No. 4%) No. (5;) No. (%I p Value 
osis after angioplasty 27-r 16 26 + 16 27 + 11 NS 
9.708 (90.0) 2,582 (90.8) 7.126 (89.7) 0.12 
tion 88 (0.8) 30 (1.1) 58 (0.7) o.io 
EmergmcY =ftery 227 (2.1) 60 (2.1) 167 (2.1) 
bhospitai death 30 (0.3) 21 (0.7) 9 (0.1) < 1 
CXnical success 9,548 (88.5) 2.529 (88.9) 7,019 (88.4) 
Angina at late follow-up 2,775 (30.3) 972 (40.2) 1,803 (26.7) < I 
Time Iyr) 3.6 it 2.8 3.2 rt 2.7 3.1 + 2.9 < I 
Data presented are mean values zz SD or number (c/c) of patients. 
Table 5. Each of the preangioplasty variables considered in
Tables I and 2, variables generally available and previously 
considered as correlates of survival, were considered as 
potential correlates inthis study. The univariate correlates 
were female gender, educed ejection fraction, short stature, 
multivessel disease, older , lower body surface area, 
lower body weight, prese of congestive heart failure, 
severe angina nd previous myocardial infarction. The mul- 
tivariate correlates were reduced ejection fraction (odds 
ratio 0.21 for ejection fraction over >50%), short stature 
(odds ratio 0.19 for height 65 to 70 in., 0.07 for height 
~70 in.) and multivessel disease (odds ratio 2.65 for multi- 
vessel disease). There were trends only for female gender 
and older age, both of which correlated with short stature. In 
this model there were only 6,202 patients and 16 deaths 
because of missing values for ejection fraction and height. 
When imputed values for height and ejection fraction were 
used, there were 10,394 ents in the model with 28 deaths. 
The mcst significant cha from the model in Table 5 to this 
model was that he p value for age decreased to 0.037, and 
the odds ratio increased to 3.68, with a 95% confidence 
interval of 1.31 to 10.33. 
The correlates of combined in-hospital and long-term 
death are shown in Table 6. The univariate correlates were 
female gender, older age, congestive heart failure, reduced 
ejection fraction, diabetes, multivessel disease, hyperten- 
sion, severe angina, previous myocardial infarction, lower 
ht. shorted stature and GOfer 
ultivessel disease, severe angina nd hyper- 
tension are less powerful predictors. 
Several lternative models were also deve 
fraction was not c~~sistemt~y collected, 
o the left in Table 7 concerns late death 
the model. This in- 
creased the number of patients from 6,318 to 9,233. The 
hazard ratios were similar to those in Table 6. Not su 
ingly, the hazard ratio for congestive failure increased from 
2.63 to 2.98, as the ejection fraction correlates with conges- 
tive failure. The middle model concerns death after hospital 
discharge. The patients who died in the hospital were not 
included in this model. As the majority of the deaths were 
late (only 30 in hospital), it is not surprising that he model 
closely resembled the model in Table 6. The relatively 
marginal variable, angina class, was no longer significant. In 
4. Interelation of Age, Height and Gender and In-Hospital Mortality 
(Yr) 
Go 
64-70 
>70 
He&&t ,.) 
-355 
65-70 
>70 
Pts = patients. 
No. of 
hS 
5,868 
3,549 
1,361 
1,686 
3.594 
3.966 
Total Women Men 
p Value 
No. of No. of No. of No. of No. of (Fisher 
Deaths (%b) FtS Deaths t%%) PtS Deaths (%) exact test) 
-- 
6 (0.1) 1.138 3 (0.3) 4.730 3 (0.1) 0.091 
10 (0.3) 1.069 6 (0.6) 2.480 4 (0.2) 0.076 
14 (I.01 636 I2 (I.91 725 2 (0.3) 0.005 
IS (0.9) 1,394 14 (I.01 292 I (0.3) 0.49 
4 (0.1) 936 2 (0.2) 2.65% 2 (0.1) 0.28 
3 (0.1) 83 0 3,883 3 (0.1) 1.0 
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ortmlity 
Rare OR 
Univariale 
95% CP p Value 
~M~t~v~~~te (na = 6,202, 16 deaths) 
OR 95% CB p Value 
- 
Gender 
en 
Women 
Ejection fmclion (%,P 
GO 
SSO 
eight (in.1 
<65 
65-7 
>7o 
No. of ve5dels diseased 
2-3 
Age (~0 
c60 
60-70 
490 
Body sulhce area (d 
c1.7 
1.9-1.8 
1.8 
Weight (Ib) 
<M-I 
m-175 
>I95 
Congestive heart failure 
Absent 
Present 
Angina class 
0-u 
ID-IV 
Previous mvocardial infarction 
Abseat 
Present 
9 
21 
15 
4 
I2 
18 
6 0. I 1.00 
10 0.3 2.76 
14 I.0 10. IS 
IO 
6 
6 
IO 0.6 P.cG 
9 0.3 0.44 
6 0.1 0.21 
24 
4 
4 
25 
14 0.2 1.00 
16 0.4 2.20 
0.1 
0.7 
0.3 
0.2 
0.9 
0.1 
0.1 
0.2 
0.6 
0.8 
0.6 
0.1 
0.2 
1.4 
0.1 
0.4 
1.00 
6.55 
I .oo 
9.12 
0.08 
1.00 
3.60 
1.00 
0.92 
0.10 
I.@0 
6.15 
I.110 
3.86 
3.00-14.32 
0.09-0.46 
0.04-0.39 
5.024-0.29 
1.73-1.48 
I .003-9.60 
3.90-26.47 
0.26-1.99 
0.038-0.29 
0.19-1.15 
0.08-0.58 
2.12-19.84 
1.34-11.10 
1.07-4.51. 
< O.ooQl 
I.00 
1.74 0.39-7.69 
1.00 
2.00 0.49-8.15 
3.29 O.81- 13.36 
0.0094 
0.0067 
0.0036 
u.032 
OR = odds ratio; CI = con 
left. Gender was not a significant correlate ofde 
these models. To examine the relation between age and 
gender on survival, models that age and gender alone are 
considered in Table 8. The model on the left is for total 
survival, and that on the right for la;,: survival with patients 
dying in the hospital excluded. Gender is a stronger univari- 
ate correlate of in-hospital p us late death than of late death 
eless, in each case the higher mortality among 
be accounted for entirely by their older age. 
rveS in women and men are displayed in 
Figure 1. In univariate eier curves, survival in 
women is consistently lower than that in men. Calculated 
survival, corrected for baseline differences, using the Cox 
model analysis from Table 6, is presented in Figure 2. This 
mode1 assumed mean values for the entire population of57.9 
years of age, 2.7% congestive failure, 58% ejection fraction, 
13.7% diabetes, 29.5% multivessel disease, 61.9% class 111 
d 43.9% hy~e~emsio~. 
rence in survival between women and me 
myocardial infarction ispresented in Figu 
nce between women and men was noted. 
~iflni~arly, f eedom from coronary surgery and 
repeat angioplasty are displayed in Figures 4 a 
were more additional procedures, either co 
plasty or coronary surgery, in men than in women. 
habitus, yet had less multivessel disease and 
left ventricular funct 
tions and higher ejection fractions) than men. There was 
essentially no difference inangiographic outcome. Nonethe- 
less, the in-hospital mortality in women was considerably 
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p value 
pI 
Gender 
Male 
Female 
& (yr) 
a0 
60-70 
>70 
c live heart failure 
Absent 
Present 
Ejection fraction (‘lb) 
CSQ 
a50 
Diabetes 
Absent 
Rcwnt 
No. of vewls dixrd 
1 
2-3 
Hyphens 
Absent 
Resent 
An&a &ss 
en 
III-IV 
Rwious myocdid iufarction 
AbSCnt 
Present 
Weight (lb) 
<Ix, 
M-175 
>I’15 
Height (in.) 
c65 
65-70 
>70 
Body surface area Ima) 
a.7 
I .7-1.8 
S1.8 
1.00 
1.4s 
I.00 
4.77 
1.00 
2.24 
1.00 
1.82 
1.00 
1.64 
1.00 
1.87 
I.00 
0.91 
0.71 
1.00 
0.80 
0.71 
:.Oa 
I .07 
0.78 
1.22-1.80 
1.99-3.08 
4.59-7.42 
3.48-6.55 
0.35-0.57 
I .80-2.79 
1.51-2.19 
1.36-1.97 
1.53-2.30 
1.24-1.80 
0.69-I 20 
0.56-0.93 
0.61-1.04 
0.55-0.93 
0.71-1.55 
0.59-1.03 
c O.a@Ol 
0.02 
0.05 
0.05 
1. 
1.65 
I.00 
1.25 
0.84-l .39 
1.55-2.72 
3.@9-5.70 
0.97-I 62 
0.0056 
0.016 
0.0778 
NS 
NS 
NS 
NS 
HR = hazard ratio: Ct = confidence interval 
higher than that in men. This difference inmortality coulld be 
ly explained by older age and shorter stature in women. 
Older age was a multivariate correlate of in-hospital death 
after values had been imputed from missing ejection frac- 
tions and height, and 25% of women >70 years old ac- 
of the deaths. Although short stature was a 
strong correlate of death, it is also not entirely clear that 
shon stature is primarily the variable responsible for the 
elevated risk, as shorter stature may be a proxy for some other 
variable r lated to smaller body habitus. Modeling in-hospital 
outcome was ditlicult because ofthe smali number of deaths, 
and thus the confidence intervals are wide. The long-term 
outcome isgmtifyir~& similar for women and men, especially 
after accounting for the difference in age. The models for 
long-term death are robust with relatively narrow confidence 
intervals because there are XI0 deaths and a relatively small 
number ofvariables. 
on in women. Multiple studies have xam- 
er angioplasty. Detre et al. (14) compared 
the in-hospital outcome of patients in the 1977 to 1981 
NHLBI angioplasty registry to the 1985 to 1986 registry. 
There were 1,155 patients inthe initial registry (25% women) 
and 1,802 in the new registry (26% women). In the 
registry, mortality declined in single-vessel disease: 
there was improved angiographic and clinical success. Qut- 
come in women was addressed in subsequent publications. 
Talley et al. (15) studied in-hospital nd 5-year outcomes 
after coronary angioplasty in 427 patients undergoing angio- 
Late Death Only, EF wt 
- -pl__- 
p V&e HM p V&e HR 
_---_. 
Age (yrk 
<60 1 .oo 
60-70 2.27 2.08 
>70 4.49 4.16 
Congestive heart failure < O.wOP 
Absent I .oo 1.00 
Present 2.98 2.60 
ection fraction 
<5O% 1.w 
250% 0.54 
Diabetes O.OOO1 
Absent 1.00 I .OO 
Present I .6S I.81 
No. of vessels diseased O.Otw O.Ol9 
I I. 1.00 
2-3 1.51 I.34 
~~y~e~te~s~o~ 0.024 O.O?N 
Absent I .QO I.00 
Present 1.25 1.31 
Angina class *: 0.0001 0.17 
Q-ll 1.00 1.00 
111-I!/ I .j3 1.20 
mp- 
EF in (out) = ejection fraction included in (excluded from) the model; HR = hazard ratio. 
p Value 
C O.owl 
I!.ImKl3 
0.w 
0.0003 
HR 
2.28 
4.37 
i.00 
2.94 
I.50 
1.69 
I.00 
1.47 
1.00 
1.25 
1.00 
1.48 
plasty in 198 i ,of whom 22.7% were w ra. c~~~i~a~ slKcess 
was achieved in77.3% ofpatieats, an re were no deaths. 
Survival after 5 years was 94%; the i~~ue~~~ of ;ender on 
e was not stud 
ty, ~o~~em~or 
~~e~tzjg’s original series (14). Iln th 
success was hieved in 133 (79%) 
15% of the patients were women. 
In the 1985 to 1986 I angio~lasty registry, multivessel 
disease was correlated with more frequent death, myxardial 
infarction and need for coronary surgery by I year (17). 
Differences between women and men have been noled 
previously. Inthe 1977 to 1988 
there was a lower success r 
women (5). Late mortality was noa 
sure 0uP of 8,20? 
As in the present study, the women were older and bad more 
hy~e~e~sio~, diabetes and severe angina. T 
ital death (0.3%) in wo 
(0.09%). Follow-up was less a focus oft 
study than of Ithis one. At an average of20 months, women 
Table 8. Interrelation of Age and Gender on Late Survival 
In-Hospital and Late Survival 
Univaria:e Multivariate (n = 9.957) 
p Value HR p Value HR 
Age (yrl < 0.0001 < 0.ooo1 
C60 1.00 I.00 
60-70 2.48 2.45 
>70 5.84 5.66 
Gender 0.0001 0.24 
Male I .oo I.00 
Female 1.48 I.13 
HR = hazard ratio. 
- 
Late Swival 
Univariate Multivariate (n = 9,927) 
p Value HR p Value HR 
< G.oool < 0.0001 
I.00 1.00 
2.47 2.47 
5.58 5.56 
0.003 0.92 
!.W I.00 
1.32 1 .Ol 
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1. Eight-year survival after angioplasty in women and men. 
did not differ from men in incidence ofmyocardia! infarction 
or additional procedures. A more recent Cleveland Clinic 
study (20), which presumably included many of the same 
patients, found a higher in-hospital mortality in women. 
Kelsey et a!. (7) reported results of the 1985 to 1986 WMLBI 
registry. Women had higher rates of complications and 
in-hospital mortality (2.6% vs. 0.3%). There was Iittle differ- 
ence in 4-year outcome. These results were similar to those 
in the present study, although the mortality was lower in the 
data Dresented here. The present study is also more focused 
toward long-term outcome. 
Several recent preliminary studies have focuse 
ferences between women and men. Steen et a!. (21) noted a 
death rate of 0.13% in 2,188 men and 0.31% in 1,231 women 
after coronary angioplasty, a difference that did not reach 
statistical significance. Moran et al. (22) studied outcome of 
an@p!asty in the years 1988 to 1990 in 392 women and 1,471 
2. Eight-year survival after angioplasty in women and men, 
corrected for baseline differences in correlates of survival. 
o*;_I~~~~ ._.. .-- _~ -. ._.. -~...~‘i 
. 
0s 1 .-1.. ! 
os¶ 1 . .: I 
0.92 I / 
(&y&&)0.9 i ._ 
0.88 : 
036 : / 
Rim / 
0.u 1 P=NNS 
0.82 I 
W0ttltM / 
lJ.si -..._. L7_~r_~ _.._.. . ______. _ 
, 
b 
_ _ __j 
I 2 3 c 5 6 
Time in Years 
i 8 
Mea 
.93 .92 .% 
_98 .Yf .% .94 .93 .91 .89 
aide 3. ~i~~~-y~ar freedom from ~yoc~di~l ~ofarc~ion ( 
an~oplas~y in women and men. 
statistical siEni~~~nce. Phi 
term outcome of coronary 
1981 registry; at 7 ye 
long-term outcome. Fishman et a!. (2 
atherectamy. §imi!arly, Agmw~ et ai. (24) noted more fre- 
re 4. Eighht-year freedom from coronary artery bypass graft 
surgery (CAN3 after angioplasty in women and men. 
0.8 J 
Fimdom / 
cm”*7s i 
0.7 : 
0.65 j P=.@l 
0.6 / 
, 
0.55 
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0.6 . 
ed in the CASS 
women (29-31). Two studies have shown 
s. This study provides 
detailed ata on the outcome of coronary angioplasty in men 
and women. Because the majority of patients in most studies 
have been men, the information on women warrants empha- 
sis. Does the study provide help in determining who should 
have angioplasty? In part it does, because it is worthwhile to
know in advance what o expect of aprocedure. However, if
coronary angioplasty was not performed, perhaps appropri- 
ately, in some higher risk women from the underlying 
population from which the patients inthis study were drawn, 
then the risk in some women in whom angioplasty is con- 
templated would be higher than reported here. This referral 
bias always applies when outcome of an invasive form of 
therapy is applied to patients who have not yet had the 
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